A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy
In normal cells p53 is activated by DNA damage checkpoint kinases to simultaneously control the G1/S and G2/M cell cycle checkpoints through transcriptional induction of p21[superscript cip1] and Gadd45α. In p53 mutant tumors, cell cycle checkpoints are rewired, leading to dependency on the p38/MK2...
Main Authors: | Grant, Robert A., Tsao, Ming-Sound, Cannell, Ian Gordon, Merrick, Karl Andrew, Morandell, Sandra M., Grant, Robert A, Cameron, Eleanor Ruth, Hemann, Michael, Yaffe, Michael B, Braun, Christian Joerg |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/105498 https://orcid.org/0000-0003-4082-0292 https://orcid.org/0000-0002-5229-8748 https://orcid.org/0000-0003-0179-9216 https://orcid.org/0000-0002-9547-3251 |
Similar Items
-
Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints
by: Kong, Yi Wen, et al.
Published: (2021) -
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
by: Pfirschke, Christina, et al.
Published: (2018) -
DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization
by: Reinhardt, H. Christian, et al.
Published: (2014) -
Suppression of Rev3, the catalytic subunit of Pol zeta, sensitizes drug-resistant lung tumors to chemotherapy
by: Doles, Jason D., et al.
Published: (2011) -
Unraveling Tumor Suppressor Networks with In Vivo RNAi
by: Braun, Christian Joerg, et al.
Published: (2015)